H1 To Incorporate Key Opinion Leader Data In Veeva CRM Platform

H1 combined with Veeva CRM will help life sciences clients find the right influencers in minutes instead of months

New York, New York, UNITED STATES

NEW YORK, Sept. 10, 2018 (GLOBE NEWSWIRE) -- H1, the first company to arm healthcare organizations with live data insights to help fight diseases, today announced that it has integrated H1’s Key Opinion Leader (KOL) data solution, H1 Curie, in Veeva CRM.

H1 Curie helps medical affairs organizations identify, analyze and apply critical information surrounding thought leaders. With this information in hand, life sciences companies can be sure they are communicating with the right influencers in their space, to accelerate their scientific platform and stakeholder engagement. Veeva CRM incorporates KOL Data to make it simpler for clients to identify and connect with influencers.

“Connecting with key opinion leaders is a top goal for medical affairs offices, and a process that can take weeks or months of research traditionally,” said Ariel Katz, Chief Product Officer of H1. “H1’s Curie process takes that down to minutes, with real-time data feeds and all the relevant background information needed for each influencer. We’re excited to work with Veeva to bring H1 Curie to a broader set of life sciences companies.”

H1 Curie integration with Veeva CRM is available now. Learn more about H1 Curie at https://h1insights.com/curie. Learn more about Veeva CRM at https://www.veeva.com/products/multichannel-crm/crm/.

About H1
H1 is the first company to arm healthcare organizations with live data insights to help fight diseases. The company provides real-time data from across the data universe to support the end-to-end therapeutic development process from fundraising to product development to product launch, helping healthcare and life sciences companies make smarter scientific decisions. Working with medical affairs and strategy teams who span all phases of the development lifecycle, H1 provides the complete picture of institutions, experts, scholarly content, markets, competitors and new opportunities through research grounded in actual data and clinical findings. Learn more at https://h1insights.com/.

Media contact:
Michelle Faulkner
+1 617-510-6998